Increasing Prevalence of Chronic Kidney Diseases Globally to Support Growth of Hemodialysis Market

Tue, 14 May 2019 3:36

Dialysis is the process used to clean blood by removing extra fluid when the kidneys are not working properly. There are two different types of dialysis, namely hemodialysis and peritoneal dialysis.

According to the Centres for Disease Control and Prevention, in 2016, approximately 30 million people or 15% of U.S. adults were estimated to have chronic kidney diseases (CKD). Over 2 million people worldwide receive treatment with dialysis or a kidney transplant to stay alive. Apart from this, increasing prevalence of kidney failure, owing to the increasing smoker population and prevalence of obesity and other chronic diseases. Overuse of drugs toxic to the kidneys has also been contributing to the rising incidences of kidney diseases, which, in turn, has been creating demand for hemodialysis

Segmentation Insights

The hemodialysis market has been segmented by type, product & service, and end user.

On the basis of type, the market can be segmented into conventional, daily, and nocturnal. The daily segment is expected to hold a major market share during the forecast period.

Based on product and service type, the market can be segmented into equipment, consumable, drug, and service. Among these, the consumable segment is expected to lead the market during the forecast period.

On the basis of end user, the market can be segmented into in-center dialysis, hospitals, independent dialysis centers, home dialysis, and peritoneal dialysis. The home dialysis segment is expected to hold a major market share, owing to cost-effectiveness and flexibility of scheduling.

Regional Insights

Geographically, the global hemodialysis market has been segmented into North America, Europe, Asia- Pacific, and LAMEA.

North America is projected to hold a significant market share during the forecast period, 2019–2018. According to the Centers for Disease Control and Prevention, 1 of every 7 Americans has been diagnosed with chronic kidney diseases, of which approximately 64% men were end-stage renal disease. Men were observed to be 64% more susceptible to develop end-stage renal disease as compared to women in the U.S. Prevalnce of kidney diseases among the geriatric population has also been providing impetus to market growth.

Europe is expected to witness significant growth in the global hemodialysis market during the forecast period.  According to a report published by NHS Kidney Care, every 1 in 7 U.S. adults has been diagnosed with chronic kidney disease.

Asia Pacific is a key region for the hemodialysis market. Approximately 19% of the Indian population suffers from kidney diseases. Furthermore, the sizable patient pool of people suffering from kidney and heart diseases is another key factor contributing to the increasing prevalence of kidney diseases.

Latin America is expected to witness steady growth, owing to increasing awareness regarding kidney diseases and steady growth of the healthcare sector. On the other hand, the Middle East & Africa region holds the least market share, due to the poor healthcare infrastructure, limited availability of funds, and low spending power in Africa.

Key Players

Major players in the hemodialysis market are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, and NxStage Medical, Inc. Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc.